Search results

• National Clinical Trials Network
  |Term=National Clinical Trials Network ...ials Network (NCTN) assists these organizations in developing new clinical trials and administering their regulatory, financial, membership and scientific co
  2 KB (218 words) - 14:34, 13 January 2023
• NCTN
  .... The NCTN supports these organizations in the development of new clinical trials and in the administration of their regulatory, financial, membership and sc |Type=Cancer terms
  1 KB (207 words) - 12:15, 13 January 2023
• Abituzumab
  ...various [[cancer]] types and [[fibrosis]]. It is currently under clinical trials. ...ion and migration, processes that are crucial for the growth and spread of cancer cells.
  1 KB (162 words) - 23:33, 3 February 2024
• TroVax
  ...ceutical company. It is designed to stimulate the immune system to destroy cancer cells. ...ombination of the words "tumor" and "vaccine", reflecting its purpose as a cancer vaccine.
  1 KB (166 words) - 21:05, 4 February 2024
• Demcizumab
  ...em-siz-u-mab) is a [[monoclonal antibody]] designed for the treatment of [[cancer]]. It is developed by [[OncoMed Pharmaceuticals]] and is currently in the c ...ocking this pathway, demcizumab can potentially stop or slow the growth of cancer cells.
  1 KB (169 words) - 02:36, 6 February 2024
• Seribantumab
  ...i-ban-tu-mab) is a [[monoclonal antibody]] designed for the treatment of [[cancer]]. It is developed by [[Merrimack Pharmaceuticals]] and is currently in the ...ng this receptor, Seribantumab can inhibit the growth and proliferation of cancer cells.
  1 KB (172 words) - 02:53, 7 February 2024
• Adavosertib
  ...investigation for its potential use in the treatment of various types of [[cancer]]. It is specifically designed to inhibit the activity of [[Wee1]], a prote ...to cell death. This mechanism of action is particularly effective against cancer cells, which often have defects in their cell cycle checkpoints.
  2 KB (218 words) - 14:52, 6 February 2024
• Ficlatuzumab
  ...s by blocking the activity of a specific protein in the body that promotes cancer growth. ...By blocking this pathway, Ficlatuzumab can slow down or stop the growth of cancer cells.
  1 KB (165 words) - 00:04, 7 February 2024
• Lucitanib
  ...ent of various types of [[cancer]], including [[breast cancer]] and [[lung cancer]]. ...ame signifies the drug's function as a beacon of hope in the fight against cancer.
  2 KB (209 words) - 20:05, 5 February 2024
• Seviteronel
  ...for its potential use in the treatment of [[prostate cancer]] and [[breast cancer]]. It is being developed by Innocrin Pharmaceuticals. ...y slow the growth of hormone-dependent cancers such as prostate and breast cancer.
  1 KB (208 words) - 00:16, 7 February 2024
• COG
  ...clinical trials that test new ways of preventing, diagnosing and treating cancer in children and adolescents.  |Type=Cancer terms
  1 KB (159 words) - 08:27, 8 January 2023
• Ertumaxomab
  ...cer]]. It is unique in its ability to bind three different types of cells: cancer cells, [[T cells]], and [[accessory cells]]. ...ding triggers a complex immune response, leading to the destruction of the cancer cell.
  1 KB (181 words) - 17:54, 6 February 2024
• Action Study
  ...studies that focus on finding out whether actions people take can prevent cancer  |Type=Cancer terms
  502 bytes (66 words) - 04:05, 8 January 2023
• Andecaliximab
  ...MMP-9), a protein often found in high levels in tumors and associated with cancer progression. ==Clinical Trials==
  1 KB (186 words) - 02:35, 7 February 2024
• Onartuzumab
  ...e [[MET receptor]], a protein often found in high levels on the surface of cancer cells. ...thereby inhibiting the receptor's activity. This can lead to a decrease in cancer cell growth and proliferation.
  1 KB (163 words) - 17:24, 6 February 2024
• Enadenotucirev
  ...non-replicating adenovirus that is being studied for its potential use in cancer treatment. ...cancer, including [[colorectal cancer]], [[ovarian cancer]], and [[bladder cancer]].
  2 KB (244 words) - 04:51, 7 February 2024
• Vadimezan
  ...s a small molecule [[inhibitor]] that was developed for the treatment of [[cancer]]. It is also known by its chemical name, DMXAA (5,6-dimethylxanthenone-4-a ==Clinical Trials==
  1 KB (169 words) - 22:58, 5 February 2024
• Lucatumumab
  ...-too-moo-mab) is a [[monoclonal antibody]] designed for the treatment of [[cancer]]. It was developed by [[Novartis]], a Swiss multinational pharmaceutical c ...ancer cells. This binding triggers an immune response that can destroy the cancer cells.
  1 KB (155 words) - 17:25, 6 February 2024
• Sibrotuzumab
  ...a [[monoclonal antibody]] designed for the treatment of certain types of [[cancer]]. It was developed by [[Boehringer Ingelheim]], a German pharmaceutical co .... By binding to FAP, Sibrotuzumab inhibits the growth and proliferation of cancer cells.
  1 KB (172 words) - 02:23, 7 February 2024
• AG3340
  ...ouron Pharmaceuticals]] and is primarily used in the research of various [[cancer]] types. ...prevent the breakdown of the ECM, which is a key process in the spread of cancer cells.
  1 KB (180 words) - 23:16, 3 February 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)